A two unit antisense RNA cassette test system for silencing of target genes (original) (raw)

Abstract

This communication describes a two unit antisense RNA cassette system for use in gene silencing. Cassettes consist of a recognition unit and an inhibitory unit which are transcribed into a single RNA that carries sequences of non-contiguous complementarity to the chosen target RNA. The recognition unit is designed as a stem-loop for rapid formation of long- lived binding intermediates with target sequences and resembles the major stem-loop of a naturally occurring antisense RNA, CopA. The inhibitory unit consists of either a sequence complementary to a ribosome binding site or of a hairpin ribozyme targeted at a site within the chosen mRNA. The contributions of the individual units to inhibition was assessed using the lacI gene as a target. All possible combinations of recognition and inhibitory units were tested in either orientation. In general, inhibition of lacI expression was relatively low. Fifty per cent inhibition was obtained with the most effective of the constructs, carrying the recognition stem-loop in the antisense orientation and the inhibitory unit with an anti-RBS sequence. Several experiments were performed to assess activities of the RNAs in vitro and in vivo : antisense RNA binding assays, cleavage assays, secondary structure analysis as well as Northern blotting and primer extension analysis of antisense and target RNAs. The problems associated with this antisense RNA approach as well as its potential are discussed with respect to possible optimization strategies.

Full Text

The Full Text of this article is available as a PDF (401.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman S. RNA enzyme-directed gene therapy. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10898–10900. doi: 10.1073/pnas.90.23.10898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERTANI G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol. 1951 Sep;62(3):293–300. doi: 10.1128/jb.62.3.293-300.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berzal-Herranz A., Joseph S., Burke J. M. In vitro selection of active hairpin ribozymes by sequential RNA-catalyzed cleavage and ligation reactions. Genes Dev. 1992 Jan;6(1):129–134. doi: 10.1101/gad.6.1.129. [DOI] [PubMed] [Google Scholar]
  4. Berzal-Herranz A., Joseph S., Chowrira B. M., Butcher S. E., Burke J. M. Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. EMBO J. 1993 Jun;12(6):2567–2573. doi: 10.1002/j.1460-2075.1993.tb05912.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berzal-Herranz A., Wagner E. G., Díaz-Orejas R. Control of replication of plasmid R1: the intergenic region between copA and repA modulates the level of expression of repA. Mol Microbiol. 1991 Jan;5(1):97–108. [PubMed] [Google Scholar]
  6. Blomberg P., Wagner E. G., Nordström K. Control of replication of plasmid R1: the duplex between the antisense RNA, CopA, and its target, CopT, is processed specifically in vivo and in vitro by RNase III. EMBO J. 1990 Jul;9(7):2331–2340. doi: 10.1002/j.1460-2075.1990.tb07405.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bouvet P., Belasco J. G. Control of RNase E-mediated RNA degradation by 5'-terminal base pairing in E. coli. Nature. 1992 Dec 3;360(6403):488–491. doi: 10.1038/360488a0. [DOI] [PubMed] [Google Scholar]
  8. Case C. C., Simons E. L., Simons R. W. The IS10 transposase mRNA is destabilized during antisense RNA control. EMBO J. 1990 Apr;9(4):1259–1266. doi: 10.1002/j.1460-2075.1990.tb08234.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chowrira B. M., Berzal-Herranz A., Burke J. M. Ionic requirements for RNA binding, cleavage, and ligation by the hairpin ribozyme. Biochemistry. 1993 Feb 2;32(4):1088–1095. doi: 10.1021/bi00055a014. [DOI] [PubMed] [Google Scholar]
  10. Chowrira B. M., Berzal-Herranz A., Burke J. M. Novel guanosine requirement for catalysis by the hairpin ribozyme. Nature. 1991 Nov 28;354(6351):320–322. doi: 10.1038/354320a0. [DOI] [PubMed] [Google Scholar]
  11. Chowrira B. M., Burke J. M. Binding and cleavage of nucleic acids by the "hairpin" ribozyme. Biochemistry. 1991 Sep 3;30(35):8518–8522. doi: 10.1021/bi00099a003. [DOI] [PubMed] [Google Scholar]
  12. Couture L. A., Stinchcomb D. T. Anti-gene therapy: the use of ribozymes to inhibit gene function. Trends Genet. 1996 Dec;12(12):510–515. doi: 10.1016/s0168-9525(97)81398-4. [DOI] [PubMed] [Google Scholar]
  13. Daugherty B. L., Hotta K., Kumar C., Ahn Y. H., Zhu J. D., Pestka S. Antisense RNA: effect of ribosome binding sites, target location, size, and concentration on the translation of specific mRNA molecules. Gene Anal Tech. 1989 Jan-Feb;6(1):1–16. doi: 10.1016/0735-0651(89)90007-1. [DOI] [PubMed] [Google Scholar]
  14. Dretzen G., Bellard M., Sassone-Corsi P., Chambon P. A reliable method for the recovery of DNA fragments from agarose and acrylamide gels. Anal Biochem. 1981 Apr;112(2):295–298. doi: 10.1016/0003-2697(81)90296-7. [DOI] [PubMed] [Google Scholar]
  15. Farabaugh P. J. Sequence of the lacI gene. Nature. 1978 Aug 24;274(5673):765–769. doi: 10.1038/274765a0. [DOI] [PubMed] [Google Scholar]
  16. Gerhart E., Wagner H., Nordström K. Structural analysis of an RNA molecule involved in replication control of plasmid R1. Nucleic Acids Res. 1986 Mar 25;14(6):2523–2538. doi: 10.1093/nar/14.6.2523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gray J., Picton S., Shabbeer J., Schuch W., Grierson D. Molecular biology of fruit ripening and its manipulation with antisense genes. Plant Mol Biol. 1992 May;19(1):69–87. doi: 10.1007/BF00015607. [DOI] [PubMed] [Google Scholar]
  18. Hjalt T. A., Wagner E. G. Bulged-out nucleotides in an antisense RNA are required for rapid target RNA binding in vitro and inhibition in vivo. Nucleic Acids Res. 1995 Feb 25;23(4):580–587. doi: 10.1093/nar/23.4.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hjalt T. A., Wagner E. G. Bulged-out nucleotides protect an antisense RNA from RNase III cleavage. Nucleic Acids Res. 1995 Feb 25;23(4):571–579. doi: 10.1093/nar/23.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hjalt T., Wagner E. G. The effect of loop size in antisense and target RNAs on the efficiency of antisense RNA control. Nucleic Acids Res. 1992 Dec 25;20(24):6723–6732. doi: 10.1093/nar/20.24.6723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Homann M., Rittner K., Sczakiel G. Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1. J Mol Biol. 1993 Sep 5;233(1):7–15. doi: 10.1006/jmbi.1993.1480. [DOI] [PubMed] [Google Scholar]
  22. Inokuchi Y., Yuyama N., Hirashima A., Nishikawa S., Ohkawa J., Taira K. A hammerhead ribozyme inhibits the proliferation of an RNA coliphage SP in Escherichia coli. J Biol Chem. 1994 Apr 15;269(15):11361–11366. [PubMed] [Google Scholar]
  23. Junn E., Kang C. Detection of hammerhead ribozyme-mediated cleavage and reduced expression of LacZ' mRNA in E. coli. Genet Anal. 1996 May;13(1):1–7. doi: 10.1016/1050-3862(96)00138-6. [DOI] [PubMed] [Google Scholar]
  24. Kittle J. D., Simons R. W., Lee J., Kleckner N. Insertion sequence IS10 anti-sense pairing initiates by an interaction between the 5' end of the target RNA and a loop in the anti-sense RNA. J Mol Biol. 1989 Dec 5;210(3):561–572. doi: 10.1016/0022-2836(89)90132-0. [DOI] [PubMed] [Google Scholar]
  25. Malmgren C., Wagner E. G., Ehresmann C., Ehresmann B., Romby P. Antisense RNA control of plasmid R1 replication. The dominant product of the antisense rna-mrna binding is not a full RNA duplex. J Biol Chem. 1997 May 9;272(19):12508–12512. doi: 10.1074/jbc.272.19.12508. [DOI] [PubMed] [Google Scholar]
  26. Matteucci M. D., Wagner R. W. In pursuit of antisense. Nature. 1996 Nov 7;384(6604 Suppl):20–22. [PubMed] [Google Scholar]
  27. Miller J. H., Coulondre C., Farabaugh P. J. Correlation of nonsense sites in the lacI gene with specific codons in the nucleotide sequence. Nature. 1978 Aug 24;274(5673):770–775. doi: 10.1038/274770a0. [DOI] [PubMed] [Google Scholar]
  28. Milligan J. F., Matteucci M. D., Martin J. C. Current concepts in antisense drug design. J Med Chem. 1993 Jul 9;36(14):1923–1937. doi: 10.1021/jm00066a001. [DOI] [PubMed] [Google Scholar]
  29. Nellen W., Lichtenstein C. What makes an mRNA anti-sense-itive? Trends Biochem Sci. 1993 Nov;18(11):419–423. doi: 10.1016/0968-0004(93)90137-c. [DOI] [PubMed] [Google Scholar]
  30. Nordström K., Wagner E. G. Kinetic aspects of control of plasmid replication by antisense RNA. Trends Biochem Sci. 1994 Jul;19(7):294–300. doi: 10.1016/0968-0004(94)90008-6. [DOI] [PubMed] [Google Scholar]
  31. Persson C., Wagner E. G., Nordström K. Control of replication of plasmid R1: formation of an initial transient complex is rate-limiting for antisense RNA--target RNA pairing. EMBO J. 1990 Nov;9(11):3777–3785. doi: 10.1002/j.1460-2075.1990.tb07591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Persson C., Wagner E. G., Nordström K. Control of replication of plasmid R1: kinetics of in vitro interaction between the antisense RNA, CopA, and its target, CopT. EMBO J. 1988 Oct;7(10):3279–3288. doi: 10.1002/j.1460-2075.1988.tb03195.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Persson C., Wagner E. G., Nordström K. Control of replication of plasmid R1: structures and sequences of the antisense RNA, CopA, required for its binding to the target RNA, CopT. EMBO J. 1990 Nov;9(11):3767–3775. doi: 10.1002/j.1460-2075.1990.tb07590.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rittner K., Burmester C., Sczakiel G. In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res. 1993 Mar 25;21(6):1381–1387. doi: 10.1093/nar/21.6.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stanssens P., Opsomer C., McKeown Y. M., Kramer W., Zabeau M., Fritz H. J. Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers. Nucleic Acids Res. 1989 Jun 26;17(12):4441–4454. doi: 10.1093/nar/17.12.4441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tomizawa J. Control of ColE1 plasmid replication: the process of binding of RNA I to the primer transcript. Cell. 1984 Oct;38(3):861–870. doi: 10.1016/0092-8674(84)90281-2. [DOI] [PubMed] [Google Scholar]
  37. Wagner E. G., Blomberg P., Nordström K. Replication control in plasmid R1: duplex formation between the antisense RNA, CopA, and its target, CopT, is not required for inhibition of RepA synthesis. EMBO J. 1992 Mar;11(3):1195–1203. doi: 10.1002/j.1460-2075.1992.tb05160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wagner E. G., Simons R. W. Antisense RNA control in bacteria, phages, and plasmids. Annu Rev Microbiol. 1994;48:713–742. doi: 10.1146/annurev.mi.48.100194.003433. [DOI] [PubMed] [Google Scholar]
  39. Wagner R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 1994 Nov 24;372(6504):333–335. doi: 10.1038/372333a0. [DOI] [PubMed] [Google Scholar]